The Clorox Company (NYSE:CLX) Shares Sold by Hummer Financial Advisory Services Inc

Hummer Financial Advisory Services Inc decreased its holdings in The Clorox Company (NYSE:CLX) by 8.8% in the third quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 2,074 shares of the company’s stock after selling 200 shares during the quarter. Hummer Financial Advisory Services Inc’s holdings in Clorox were worth $338,000 at the end of the most recent reporting period.

Other large investors also recently bought and sold shares of the company. GoalVest Advisory LLC purchased a new stake in Clorox during the 1st quarter worth approximately $31,000. First Foundation Advisors purchased a new stake in Clorox during the 1st quarter worth approximately $31,000. Innealta Capital LLC purchased a new stake in Clorox during the 2nd quarter worth approximately $30,000. Trifecta Capital Advisors LLC increased its stake in Clorox by 139.8% during the 2nd quarter. Trifecta Capital Advisors LLC now owns 223 shares of the company’s stock worth $30,000 after buying an additional 130 shares in the last quarter. Finally, Quarry LP increased its stake in Clorox by 99.1% during the 2nd quarter. Quarry LP now owns 229 shares of the company’s stock worth $31,000 after buying an additional 114 shares in the last quarter. Institutional investors and hedge funds own 78.53% of the company’s stock.

Clorox Price Performance

Shares of NYSE:CLX traded down $1.07 on Wednesday, hitting $162.27. The company had a trading volume of 95,475 shares, compared to its average volume of 1,233,080. The company has a market cap of $20.15 billion, a PE ratio of 84.63, a PEG ratio of 3.19 and a beta of 0.41. The business has a 50 day moving average of $158.14 and a 200 day moving average of $144.85. The Clorox Company has a 52-week low of $114.68 and a 52-week high of $169.09. The company has a current ratio of 1.03, a quick ratio of 0.63 and a debt-to-equity ratio of 5.04.

Clorox (NYSE:CLX) last released its earnings results on Thursday, August 1st. The company reported $1.82 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.54 by $0.28. Clorox had a net margin of 3.95% and a return on equity of 281.12%. The firm had revenue of $1.90 billion during the quarter, compared to the consensus estimate of $1.97 billion. As a group, equities analysts anticipate that The Clorox Company will post 6.64 earnings per share for the current fiscal year.

Clorox Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Thursday, November 7th. Investors of record on Wednesday, October 23rd will be issued a $1.22 dividend. The ex-dividend date is Wednesday, October 23rd. This represents a $4.88 dividend on an annualized basis and a yield of 3.01%. Clorox’s payout ratio is 252.85%.

Insider Activity at Clorox

In related news, EVP Angela C. Hilt sold 1,733 shares of the business’s stock in a transaction that occurred on Friday, September 6th. The shares were sold at an average price of $165.52, for a total value of $286,846.16. Following the completion of the sale, the executive vice president now directly owns 13,471 shares in the company, valued at approximately $2,229,719.92. The trade was a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. 0.51% of the stock is owned by insiders.

Analysts Set New Price Targets

Several research firms recently commented on CLX. Evercore ISI cut their price target on Clorox from $140.00 to $139.00 and set an “underperform” rating for the company in a report on Monday. Jefferies Financial Group upgraded Clorox from a “hold” rating to a “buy” rating and lifted their price target for the stock from $174.00 to $187.00 in a report on Tuesday, October 1st. BNP Paribas raised shares of Clorox to a “strong sell” rating in a report on Friday, September 6th. DA Davidson reiterated a “neutral” rating and issued a $153.00 target price on shares of Clorox in a report on Friday, September 6th. Finally, JPMorgan Chase & Co. raised their price target on shares of Clorox from $148.00 to $174.00 and gave the stock a “neutral” rating in a report on Friday, October 11th. Six investment analysts have rated the stock with a sell rating, nine have issued a hold rating and one has given a buy rating to the stock. Based on data from MarketBeat.com, Clorox presently has an average rating of “Hold” and a consensus target price of $150.14.

About Clorox

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.